59 results
Page 3 of 3
6-K
zlx 4ljsjv765nh
14 Nov 19
Current report (foreign)
7:01am
6-K
EX-99.2
c8odbhd6ghte3
1 Nov 19
Current report (foreign)
4:15pm
6-K/A
eeinti27
29 Aug 19
Current report (foreign) (amended)
5:25pm
6-K
negf vdpf40
13 Aug 19
Current report (foreign)
7:00am
6-K
EX-10.1
4f7y9e56gm1j
17 May 19
Current report (foreign)
5:20pm
6-K
EX-99.2
xc1jrwaqpuox vm9
15 Oct 18
Notice of Annual General Meeting of Shareholders
8:15am
6-K
EX-1.1
ebu003
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am
6-K
EX-99.1
c97gubspnnri
20 Oct 17
VBL Therapeutics Announces Orphan Drug Designation for VB-111 In Europe
12:00am
20-F/A
EX-4.3
tj49m
11 Oct 17
Annual report (foreign) (amended)
12:00am
20-F
EX-4.18
b164673 6xk
25 Mar 15
Annual report (foreign)
12:00am
20-F
9iav5
25 Mar 15
Annual report (foreign)
12:00am
424B4
34fpt d82o
2 Oct 14
Prospectus supplement with pricing info
12:00am
424B4
ltz000zmxa
1 Aug 14
Prospectus supplement with pricing info
12:00am
F-1/A
EX-10.3
8d7j 8ogehvd
18 Jul 14
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-10.11
a3x614m 4kpj2ey43za
18 Jul 14
Registration statement (foreign) (amended)
12:00am